- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Lorlatinib is administered continuously without a fixed course of treatment and needs to be dynamically adjusted based on disease progression a...
The duration of use of Lorviqua mainly depends on disease progression and patient tolerance, and is usually continued until disease progression...
The daily dosage of Lorlatinib depends on the drug specifications and individual patient conditions. The standard dose is 100mg/day, and the sp...
The daily dosage of Lorlatinib should be determined based on the patient's condition and tolerance. The standard dosage is 100mg orally once a ...
Capmatinib is a selective MET inhibitor primarily used to treat metastatic non-small cell lung cancer with MET exon 14 skipping mutations. Its ...
The dosage of Capmatinib needs to be adjusted according to the specific situation of the patient, and is mainly suitable for adult patients wit...
The administration time of Biktarvy should strictly follow the principle of daily fixed time administration to maintain a stable blood drug con...
Biktarvy is a triple combination antiretroviral drug consisting of biktaravir, emtricitabine, and propafenone. It is used to treat HIV-1 infect...
Cabergoline is a dopamine receptor agonist derived from ergot, mainly used for the treatment of hyperprolactinemia and related diseases. It has...
The optimal time for taking Cabergoline should take into account the drug absorption characteristics, adverse reactions, and individual differe...
